Covid vac­cine mak­ers Pfiz­er, J&J notch high brand marks amid over­all still-strong phar­ma in­dus­try rep: Har­ris Poll

Can the phar­ma in­dus­try hold on­to its pan­dem­ic-mint­ed pos­i­tive rep­u­ta­tion? So far so good, ac­cord­ing to the Har­ris Poll’s lat­est da­ta. The in­dus­try seems to have sta­bi­lized pos­i­tive opin­ions in the US, now lev­el­ing off in the mid-50 per­cent ranges, da­ta from the Har­ris Poll’s most re­cent De­cem­ber sur­vey re­veal.

Mean­while, the glob­al pic­ture is even sun­nier. The phar­ma in­dus­try notched a 59% over­all pos­i­tive in­dus­try sen­ti­ment, ahead of fi­nan­cial ser­vices (51%) and in­sur­ance (47%), and not that far be­hind typ­i­cal fa­vorites like con­sumer pack­aged goods (64%) and re­tail (66%).

To read Endpoints News become a free subscriber

Unlock this article instantly, along with access to limited free monthly articles and our suite of newsletters

SIGN UP LOG IN